chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received call on 05/14/04 from client to report an allergic reaction from Immunization received on 05/10/04. Reports red hive rash generalized, called MD-instructed to take Benadryl (all this occurred within 1 hr of injection of tetanus toxoid at health dept) After taking Benadryl and sleeping about an hour later no rash or problems noted.
Patient came in to the pharmacy a few weeks later stating that she still has a sore arm. She refuses to take anything over the counter to help with discomfort. Reports having a sore arm while hiking the mountains with a heavy backpack.
Following 4/14/23 vaccination family reported patient remained more tired than usual thereafter. On 5/3 noted to have low grade temperatures (99s F) and some neck pain. On 5/4 developed unsteadiness/wobbly gate. Seen in ED but had some improvement so discharged to home. However developed fever and seen again in ED on 5/6 with ongoing unsteady gate. LP and MRI performed and findings concerning for ADEM. Treated with 5 days of solumedrol pulse with good clinical improvement.  Infectious and neuro evaluations undertaken with only major finding a positive anti-GAD cell based assay with high titer 1:1000. Patient now near baseline neurologic status.
arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026C20A and 028L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On 16-Jan-2021, PAIN IN EXTREMITY (arm pain) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-033496 (Patient Link).
ADULT OBSTRUCTIVE SLEEP APNEA, MODERATE 5/3/2023 LEFT FIBULA UNSPECIFIED TYPE DISTAL PHYSEAL FX, INIT
pt vomited approx 1 min after shots and became very pale, diaphoretic and confused. Vital signs were stable. Recovered after 5-10 minutes of lying on exam table
Pt tested positive for COVID-19  4/6/2021, s/s myalgias with unknown onset date.
Red area on left deltoid 5cm in diameter area is hot and red and painful x 2 DA. Pt advised to contact this office if s/s do not subside on its own.
The next day after receiving the vaccine I started getting a lot of mucus. It's very thick, I can hardly sleep, when it comes up it's brownish red. I am losing my voice, I get very little sleep and am extremely sore and achy all over my body. I have a low grade fever. My doctor only recommended over the counter medication for my congestion and albuterol inhaler. She said I should be well in a couple of days but I am still feeling bad.
Shingles; This spontaneous report was received from a consumer via a company representative referring to a 18 year old female patient. The patient's pertinent medical history, concomitant medications and drug allergies or reactions were not reported. On an unknown date, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) (strength, dose, route of administration, anatomical location, lot # and expiration date were unknown) for prophylaxis. The patient was vaccinated while she was a child. On an unknown date, the patient was diagnosed with shingles (herpes zoster). The patient sought medical attention for the event. The outcome of the event of herpes zoster was unknown. Causality assessment was not provided. There was no product quality complaint associated with the case.
This spontaneous case, initially received from a pharmacist on 04-Oct-2018, concerns a 32-year-old, adult female patient. On an unspecified date in Oct-2017, the patient was administered INN flu vaccine seasonal for an unknown indication and was tolerated with the product. On 03-Oct-2018, the patient was administered Influenza vaccine (dose, route of administration, anatomical location, batch number, expiry date, trade name and manufacturer: not reported). On the same day, at 8 pm, 6-7 hours after vaccination, the patient experienced a local reaction of a large area of itching (approximately 3 inches in diameter, almost looked like hives), swelling and warmth at the injection site. It was reported that the area progressively increased in size and worsened over time (condition aggravated). The patient was treated with BENADRYL on an unspecified date in Oct-2018 (reported as last night) and the reaction subsided a bit but still had a little swelling and itching. On an unspecified date Oct-2018, the patient was recovering from the event injection site warmth and not recovered from the events injection site itching, injection site swelling, and condition aggravated. The reporter assessed this case as non-serious and the events related to the suspect vaccine.
Pt received 3 vaccines - DTAP, flu (L) deltoid and polio (IPV) (R) deltoid. Received vaccines at approximately 4pm. Mom called office at 530PM with report of significant reaction (L) deltoid area 5-6# area of redness & warmth as of 11/4/11 - redness decreased but still warm to touch & swollen.
The next day on 1/15/2021 around noon I felt achy, fatigue, muscle aches, headaches, & feverish. They went from mild to sever as the day continued. This symptoms stayed severed for the next 12hrs then they went mild for the next 3 days.
Chills, severe pain in the shoulder and had difficulty moving the arm where a shot was given around 7 PM. Around 2:30 AM on way to the bathroom, passed out, fell, and hit head on hard tile floor. Was unconscious till my husband woke me up and got me off the floor.
Father of patient contacted Dr. and stated that patient was diagnosed by civilian provider that she has rash that appeared 3 days after receiving varicella immunization.
Developed flu-like symptoms 2 days ago. He said that he had chills last night, but these have resolved. He has developed a moderate sore throat. He has a cough that is productive of yellowish phlegm and he feels much better after he coughs this out.
Stiffness in both hands and sharp Pain in the right hand !!! Index & middle finger swollen !!!   Pain is still going on for 3 months till today so far continues !!!
Broad, erythematous brawny edema, temp 99.2 degrees, moderately well demarcated R lateral deltoid, no fluctuance, no proximal lymphadenitis.
patient got first covid shot, seemed fine during vaccine. 5 minutes later mom called for me and we both braced the patient as he passed out. he came to after about 10 seconds. was pale and sweaty. mom said he had passed out before during shots and finger sticks (did not inform us of this prior to vaccine). He said he felt better after 5 minutes, EMS arrived and took over from there, not sure what they did once they got him outside.
January 15th had first vaccine. The next week he was complaining with leg pain. The second vaccine was February 5th. I ended up falling February 13th. I had no factures and went to rehab. Had DVT in the right leg and put on blood thinners. I ended up with a GI bleed which required a transfusion of 3 pints of blood. They could no longer find the clot in the right leg and went back to rehab. A few days later my right leg swelled. I had a clot on my leg and two pulmonary embolisms one in each lung. A stent was placed through the clavicle bone. They performed a thrombectomy on the right leg. I was sent home and I now have a-fib problems.
Patient fainted after receiving vaccination. Rested for 15 minutes and returned to normal. Was pale and sweating. Had water provided and chair to rest. Was able to depart on own.
Pt recv vax on 11/30/98; 1 hr post vax pt exp crying > 3 hr
Generalised rash; Injection 15 mins later developed generalized rash, palpitations and rash to face. I had to go home and take medication.; Injection 15 mins later developed generalized rash, palpitations and rash to face. I had to go home and take medication.; This is a spontaneous report from a contactable Nurse for herself.   A 29-years-old female patient  received  bnt162b2 (BNT162B2; Lot # FJ1685) vaccine , intramuscular in the right arm on 19Dec2020 08:00 at single dose for covid-19 immunisation .  Medical history included drug hypersensitivity from an unknown date , food allergy from an unknown date , allergy to metals from an unknown date.  The patient 15 mins after the injection  developed generalized rash, palpitations and rash to face. and  had to go home and take medication. The outcome of the event was recovered.
arm hurt a lot after shot; still a little tender to the touch; This case was reported by a consumer and described the occurrence of pain in arm in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th September 2020, the patient received the 1st dose of Shingrix. In September 2020, less than a week after receiving Shingrix, the patient experienced pain in arm and tenderness. On an unknown date, the outcome of the pain in arm and tenderness were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm and tenderness to be related to Shingrix.  Additional details were provided as follows: The reporter reported the case for the father. The age at vaccination was not reported. The patient's arm hurt a lot after shot, arm still a little tender to the touch at the time of reporting.
Vertigo; This spontaneous case was received on 06-Oct-2020 from other health professional via Health Authority (reference number: SEQW20-02974) and concerned a 58-year-old female patient.  The patient had no medical history and was not taking any concomitant medications.  On 02-Oct-2020, the patient was vaccinated with Flucelvax QIV (influenza vaccine, subunit influenza virus vaccine polyvalent, dose: 0.5 ml, route of administration: intramuscular and anatomical location: not reported) for flu prevention. The batch number reported was 276575, expiration date: 30-Jun-2021.  On the same day, 3-4 hours after vaccination, the patient experienced vertigo.  On an unspecified date in Oct-2020, the patient took a dose of diphenhydramine (by her own).  At the time of initial reporting on 06-Oct-2020, the outcome of the event was resolving, as the patient was feeling better and reported no other ill effects.  The reporter did not provide a causality assessment.  The reporter assessed the case as non-serious.  Company comment: The patient developed vertigo 3-4 hours after vaccination with the suspect product, Flucelvax QIV. Chronology is suggestive. The patient's medical history and concomitant medications were not reported. Considering all above mentioned, causal relationship is assessed as possibly related. (defaults to ''related'' in the safety database for reporting purposes).; Sender's Comments: The patient developed vertigo 3-4 hours after vaccination with the suspect product, Flucelvax QIV. Chronology is suggestive. The patient's medical history and concomitant medications were not reported. Considering all above mentioned, causal relationship is assessed as possibly related. (defaults to ''related'' in the safety database for reporting purposes).
had the flu symptoms on vaccine 1; and was out for about 4 days on vaccine 1; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (had the flu symptoms on vaccine 1) and VACCINATION COMPLICATION (and was out for about 4 days on vaccine 1) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included Heart attack (9 Years ago.) and Artery dissection (dissected celiac artery.) in 2020. Concurrent medical conditions included Heart disease, unspecified.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA (had the flu symptoms on vaccine 1) and VACCINATION COMPLICATION (and was out for about 4 days on vaccine 1). At the time of the report, INFLUENZA (had the flu symptoms on vaccine 1) and VACCINATION COMPLICATION (and was out for about 4 days on vaccine 1) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant drugs included heart medications. Treatment medications were not provided.  It was reported that the patient did not have rash with dose 1.   This case was linked to MOD-2021-377079, MOD-2021-378957 (Patient Link).
Getting noise in her right ear/rattle noise in right ear; Body aches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Getting noise in her right ear/rattle noise in right ear), MYALGIA (Body aches) and CHILLS (Chills) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 008B21A) for COVID-19 vaccination.     Concomitant products included SUMATRIPTAN (IMITREX [SUMATRIPTAN]) for an unknown indication.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced MYALGIA (Body aches) and CHILLS (Chills). On 07-May-2021, the patient experienced TINNITUS (Getting noise in her right ear/rattle noise in right ear). The patient was treated with IBUPROFEN at an unspecified dose and frequency and DIMENHYDRINATE (DRAMAMINE) at an unspecified dose and frequency. On 05-May-2021, MYALGIA (Body aches) and CHILLS (Chills) had resolved. At the time of the report, TINNITUS (Getting noise in her right ear/rattle noise in right ear) outcome was unknown.        Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Telephone Contact Report attached.
Beginning about 30-40 minutes after the injection I noticed that my throat was feeling strange, which quickly progressed to a mild allergic reaction causing my throat to feel blocked up (at around 1 hour after shot). I also noticed mild puffiness in my cheeks and around my jaw at around the same time that I first noticed the reaction. At an hour after the injection i could feel that my throat was somewhat tight and felt as though it was blocked, but I was still able to breathe with only very mild difficulty and chose not to seek medical attention. I took a full dose of Benadryl when I first noticed the reaction (at about 40 minutes after the injection) which controlled the symptoms and at about two and a half hours after the injection I could feel that my throat was beginning to loosen up and feel less blocked
Small skin eruptions (papules) on right hand appeared on August 2. No pain or itching. These appear to be fading as if the date of this report General body aches and tiredness beginning July 31 these are the same as of the date of this report. Mild bleeding and sensitivity from gums beginning on August 1 and continuing as of the date of this report. Moderate foul taste in mouth beginning August 1, and continuing as of the date of this report.
Fever, chills, aches, fatigue for 2 days. Then lethargic and headache for 2 days.
Information has been received from a registered nurse (R.N) concerning an adult female with sulfa drug reactions who on 18-MAR-2011, was vaccinated with a dose (it was unknown if this was the first or second dose) of MMR II (Lot # not reported). About on 20-MAR-2011 "about 2 days later", the patient developed a rash. There was not description of the rash available. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
at the injection site and below the injection site, there was redness and warmth; at the injection site and below the injection site, there was redness and warmth; soreness at injection site; fatigue; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 73-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On 11th September 2019, immediately after receiving Shingrix, the patient experienced injection site pain. On 14th September 2019, the patient experienced injection site warmth and injection site erythema. In September 2019, the patient experienced fatigue. On an unknown date, the outcome of the injection site pain, injection site warmth and injection site erythema were recovering/resolving and the outcome of the fatigue was resolved with sequelae.   It was unknown if the reporter considered the injection site pain, injection site warmth, injection site erythema and fatigue to be related to Shingrix.  Additional details were provided as follows: The patient stated that he developed soreness at the injection site shortly after receiving the vaccine. The patient also noticed that at the injection site and below the injection site, there was redness and warmth and experienced fatigue that lasted for 1-2 days. The patient consented to follow up.
Started about 2-1-06. Pain radiating from back of neck down left shoulder, down left arm. Any movement causes pain.
persistent inconsolable crying lasting 4hr, starting 2hr p/vax;no swelling or redness around vax site;
Pt came in pharmacy on Monday Oct 5th and said his arm was still very sore from his vaccine.  He stated he could not lift his arm over his head without experiencing  pain and he cannot lift weights.  Called pt at his house on Oct 7th and his wife said they were still having pain and were going to the doctor on the 15th.
Severe, total body urticaria, rash, swollen lymph nodes under armpits, and facial swelling.
Mild rash to both forearms.  Mild rash to abdomen.  Mild itch to area.
This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN IN EXTREMITY (arm pain), CHILLS (Chills), LYMPHADENOPATHY (axillary lymph node swelling) and VACCINATION SITE PAIN (tenderness in the arm where injection was administered) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 17-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN IN EXTREMITY (arm pain), CHILLS (Chills), LYMPHADENOPATHY (axillary lymph node swelling) and VACCINATION SITE PAIN (tenderness in the arm where injection was administered). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 18-Mar-2021, INFLUENZA LIKE ILLNESS (Flu-like symptoms) and CHILLS (Chills) had resolved. On 19-Mar-2021, PAIN IN EXTREMITY (arm pain) had resolved. At the time of the report, LYMPHADENOPATHY (axillary lymph node swelling) and VACCINATION SITE PAIN (tenderness in the arm where injection was administered) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.
12/28/2020 - Eye Swelling 01/05/2021 - Injection site: Redness, Sore arm. Hive in injection site., itching (Brazo caliente)
I had a severe sore throat and difficulty swallowing. I had little to no fever. My oxygen was good. I felt fatigued. The sore throat lasted for about several days. I think I might've had a cough. I was tired and slept as much as I could. I went to an urgent care and they told me I was positive for COVID-19 and the flu. I was prescribed TAMIFLU and PAXLOVID. I didn't take the PAXLOVID though. I only took the TAMIFLU, and it cleared up my throat. I got better and never ended up having to take the PAXLOVID. I assume that I caught COVID-19 either overseas or on a plane. I started having symptoms right when I came back home.
This spontaneous report was received from a other health professional (healthcare student) of unknown age, regarding herself. On 18-JUN-2014 healthcare student (patient) received her first dose of GARDASIL 0.5 ml, intramuscular. On 18-AUG-2014 patient received her second dose of GARDASIL. Patient reported that immediately after she received her second dose of GARDASIL on 18-AUG-2014 and the needle was removed from an unspecified arm of hers, she saw a drop of the GARDASIL came out of the needle. Patient stated that after she saw a drop of the GARDASIL came out of the needle, she was unsure if she received the full dose of the GARDASIL. Patient also reported that she was supposed to receive her third dose of GARDASIL on 19-DEC-2014 but was unable to receive the vaccine due to development of an unspecified sickness which developed on an unspecified date. Patient stated that she was re-scheduled to receive her third dose of GARDASIL on 30-DEC-2014. Outcome of the events were unknown. No product quality complaint (PQC) was involved. Causality assessment was not provided. Additional information has been requested.
About 1 week after receiving the second Pfizer vaccine patient donated blood. Immediately after this she began to have severe fatigue, and shortness of breath.  Initially she was found to be iron deficient but this has resolved and her symptoms persist
Moderna COVID-19 Vacine  At about 6:15 PM. I developed hives on the left shoulder above injection site.  Hives were gone in about 1 hour.
#1 Moderna vaccine given on 1/21/22 at another facility.  Only 21 days between #1 Moderna (1/21/22) and #2 Moderna (2/11/22)
Headache, Myalgia, Arthralgia, Fever, chills, right arm pain Narrative:
12/18/20  1st Covid Vaccine  Lot EH9899 1/8/2021 2nd Covid Vaccine Lot EL3246 4/3/2021 Covid exposure from wife 4/7/2021 He became ill 4/12/2021 tested positive for Covid
(L) deltoid painful after injection 9-1-09 - Worsening pain - redness - swelling and warmth of area of with welts forming.
Discharge Provider: MD Primary Care Provider: MD Admission Date: 4/23/2023 Discharge Date: Apr 25, 2023  PRESENTING PROBLEM: Sepsis [A41.9]   HOSPITAL COURSE: 75 year old male with chronic urinary retention, ckd stage 3, copd, history of giant cell arteritis, history of PE, presented with complaints of sepsis from UTI and covid infection. He also had acute hypoxic respiratory failure from covid-19 pneumonia. He was started on IV remdesevir and decadron. He was also started on IV cefepime pending urine and blood cultures. Urine culture shows klebsiella so discharged on ceftin for 7 days. He weaned of oxygen to room air and respiratory status much improved.   Hyponatremia present on admission Anemia present on admission Trended labs for both. Hyponatremia resolved. Anemia may have been secondary to ckd.